IPXL - Cramer’s Take - Stockpickr ) said Tuesday that the U. Food and Drug Administration gave final approval of the company’s abbreviated new-drug application for generic versions of Alprazolam. The drug is marketed as Xanax XR by Pharmacia and Upjohn. Impax said it plans to launch the product soon. Shares of Impax, which trade on the Pink Sheets, spiked to $11. read more

Technorati Tags: , drug, impax, 11, abbreviated, administration, anxiety disorder news